Company / Total Debt
ADMA Biologics, Inc. Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$72.1M
FY2025
5-year range
$72.1M / $72.3M
FY2021-FY2025
Trend
-0.3%
vs FY2024
Sector context
#68 of 83
Health Care
What the data says
ADMA Biologics, Inc.'s total debt of $72M is lower than 82% of companies in the Health Care sector (FY2025). Increased from $0 to $72M over the past 6 years.
Based on SEC 10-K filings.
$72M in FY2025.
Increased from $0 to $72M over the past 6 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 83This company $72.1M Sector average $6.2B
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, total debt decreased 0.3% year-over-year.
- Ranks #68 out of 83 companies in the Health Care sector.
- Peak total debt was recorded in FY2024.
- Lowest total debt in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $72.1M | -0.3% |
| FY2024 | $72.3M | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $0 | -100.0% |
| FY2018 | $2.8M | +0.0% |
| FY2017 | $2.8M | +54.2% |
| FY2016 | $1.8M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026